Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

NCT00006229 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

774

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: rebimastat

Sponsor

NCIC Clinical Trials Group